TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biokjemi Norge AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,512
|
2,093
|
1,800 |
| Financial expenses |
20
|
26
|
20 |
| Earnings before taxes |
166
|
32
|
-167 |
| Total assets |
1,053
|
1,169
|
1,203 |
| Current assets |
812
|
912
|
913 |
| Current liabilities |
460
|
700
|
736 |
| Equity capital |
593
|
469
|
467 |
| - share capital |
8
|
9
|
9 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.3%
|
40.1%
|
38.8% |
| Turnover per employee |
419
|
349
|
300 |
| Profit as a percentage of turnover |
6.6%
|
1.5%
|
-9.3% |
| Return on assets (ROA) |
17.7%
|
5.0%
|
-12.2% |
| Current ratio |
176.5%
|
130.3%
|
124.0% |
| Return on equity (ROE) |
28.0%
|
6.8%
|
-35.8% |
| Change turnover |
526
|
407
|
-570 |
| Change turnover % |
26%
|
24%
|
-24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.